DEF 14A

Company

Aptevo Therapeutics Inc.

Filed

February 11, 2020

Period of Report

March 11, 2020

Accession Number

0001193125-20-031518

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →